The pharma giant had the property on the market for $11.5million, but has dropped its number by a half-million and hasbrought in Jones Lang LaSalle, which has been expanding its NewJersey presence, to sell the building. Located at 131 Docks CornerRd. in the New Jersey Turnpike Exit 8A industrial corridor, thebuilding had been used by Glaxo to ship such dental products asSensodyne and Polident.

"It is the only existing facility for sale in the area that isserved by an active rail line and has enough land to accommodateboth extensive trailer parking and future building expansion,"according to David Nenner, JLL's VP of corporate services and aspecialist in industrial sales and leases. "Its design and layoutare suitable for both light manufacturing andwarehouse/distribution operations."

"The entire industrial market here has grown exponentially inthe last few years from a sector formerly comprised of individualfamily-owned parcels to dominance by institutional investors,primarily REITs with massive multi-site, multi-state operations,"adds JLL managing director Ken Siegel. "Our presence in theimportant New Jersey market is poised for growth, and we believeour timing for expanding in the market couldn't be better.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.